Journal article
The use of alternative medical therapies in patients with systemic lupus erythematosus
Arthritis and rheumatism, v 43(6), pp 1410-1418
Jun 2000
PMID: 10857802
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Objective
As part of an ongoing study of health resource utilization and diminished productivity in patients with systemic lupus erythematosus (SLE), the use of alternative medical therapies was assessed.
Methods
A cohort of 707 patients with SLE from 3 countries completed questionnaires on demographics, social support, health status (using the Short Form 36 health survey), satisfaction with health care, health resource utilization (conventional resources and alternative therapies), and time losses in labor market and non–labor market activities. Annual direct and indirect costs (1997 Canadian dollars) were calculated and compared for users and nonusers of alternative medical therapies.
Results
Among the 707 patients, 352 (49.8%) were found to use alternative therapies and at similar rates across Canada, the United States, and the United Kingdom. Users were younger and better educated than nonusers, exhibited poorer levels of self‐rated health status and satisfaction with medical care, and had minimal to no objective evidence of worse disease (according to the revised Systemic Lupus Activity Measure instrument). The mean of log direct medical costs for conventional resources was higher for users of select alternative therapies compared with nonusers. In a logistic regression, neither the number of alternative therapies used nor the individual therapy increased the probability of incurring indirect costs.
Conclusion
The use of alternative medical therapies is common in patients with SLE. Users of many alternative medical therapies accrue greater conventional medical costs compared with nonusers. The use of alternative medical therapy may be a marker for care‐seeking behavior associated with higher consumption of conventional medical resources in the absence of demonstrable additional morbidity and should be considered in future cost analyses of patients with SLE.
Metrics
4 Record Views
Details
- Title
- The use of alternative medical therapies in patients with systemic lupus erythematosus
- Creators
- Andrew D. Moore - McGill University Health CentreMichelle A. Petri - Johns Hopkins UniversitySusan Manzi - University of PittsburghDavid A. Isenberg - University College LondonCaroline Gordon - University of BirminghamJean‐Luc Senécal - Hôpital Notre-DameYvan St. PierreLawrence Joseph - McGill University Health CentreJohn Penrod - McGill University Health CentrePaul R. Fortin - McGill University Health CentreNurhan Sutcliffe - University College LondonJean Richard Goulet - Hôpital Notre-DameDenis Choquette - Université de MontréalTamara Grodzicky - Université de MontréalJohn M. Esdaile - University of British ColumbiaAnn E. Clarke - Montreal General HospitalTrination Study Grp
- Publication Details
- Arthritis and rheumatism, v 43(6), pp 1410-1418
- Publisher
- John Wiley & Sons, Inc
- Number of pages
- 9
- Grant note
- NIH/5 (R01‐AL‐54900‐02) Lupus UK American Heart Association Arthritis Foundation Fonds de la Recherche en Santé du Québec Lupus Foundation, Western Pennsylvania Chapter NIH MAMDC (P60‐AR‐4481101) The Arthritis Society of Canada Outpatient Clinical Research Center (RR‐00722) NIH (R01‐AR‐43727)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- General Internal Medicine
- Web of Science ID
- WOS:000087503300027
- Scopus ID
- 2-s2.0-18844481708
- Other Identifier
- 991021933899104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Rheumatology